Biotechnology and Development ApS: Financial statements 2015
CVR: 33870639
Source: annual report 2015, Danish Business Authority
01/07/2014 – 30/06/2015
Biotechnology and Development ApS (CVR 33870639) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 14,168 and a net result of DKK 10,079 compared with DKK -8,985 the year before. Equity in the 2015 report amounted to DKK 4,029. The solvency ratio was 5.2%.
- Gross Profit
- DKK 14,168
- Profit/Loss
- DKK 10,079
- Equity
- DKK 4,029
- Total Assets
- DKK 78,150
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 14 t. | 10 t. | 4 t. | - |
| 2014 | - | -12 t. | -9 t. | -6 t. | - |
| 2013 | - | -6 t. | -4 t. | 3 t. | - |
Official annual report
How creditworthy is Biotechnology and Development ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Biotechnology and Development ApS
Biotechnology and Development ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2011. The company is registered under the industry Engroshandel med andre råvarer og halvfabrikata. The management consists of Karl Erik Molbech. The company is owned by KLMC Holding ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 282,184 and a net result of DKK -1,709 compared with DKK 66,166 the year before. Equity in the 2025 report amounted to DKK 105,217.